Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
Public ClinicalTrials.gov record NCT00499031. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Evaluation of Cetuximab (Erbitux®, C225, NSC# 714692) in the Treatment of Persistent or Recurrent Squamous or Non-Squamous Cell Carcinoma of the Cervix
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This phase II trial is studying cetuximab to see how well it works in treating patients with persistent or recurrent cervical cancer. Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them.
Study identification
- NCT ID
- NCT00499031
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 38 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2007 (Type not available)
- Primary completion
- Jan 2012 (Actual)
- Completion
- Not listed
- Last update posted
- Jan 13, 2015
Started 2007
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Colorado Gynecologic Oncology Group | Aurora | Colorado | 80010 | — |
| The Hospital of Central Connecticut | New Britain | Connecticut | 06050 | — |
| Decatur Memorial Hospital | Decatur | Illinois | 62526 | — |
| Saint Vincent Hospital and Health Services | Indianapolis | Indiana | 46260 | — |
| Singing River Hospital | Pascagoula | Mississippi | 39581 | — |
| CoxHealth South Hospital | Springfield | Missouri | 65807 | — |
| Island Gynecologic Oncology | Brightwaters | New York | 11718 | — |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | — |
| Stony Brook University Medical Center | Stony Brook | New York | 11794 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | — |
| Carolinas Medical Center | Charlotte | North Carolina | 28203 | — |
| Akron General Medical Center | Akron | Ohio | 44307 | — |
| MetroHealth Medical Center | Cleveland | Ohio | 44109 | — |
| Riverside Methodist Hospital | Columbus | Ohio | 43214 | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | — |
| Cancer Care Associates-Midtown | Tulsa | Oklahoma | 74104 | — |
| Tulsa Cancer Institute | Tulsa | Oklahoma | 74146 | — |
| Abington Memorial Hospital | Abington | Pennsylvania | 19001 | — |
| Women and Infants Hospital | Providence | Rhode Island | 02905 | — |
| AnMed Health Hospital | Anderson | South Carolina | 29621 | — |
| M D Anderson Cancer Center | Houston | Texas | 77030 | — |
| Froedtert and the Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00499031, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2015 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00499031 live on ClinicalTrials.gov.